R. McMillan

发表

Methoxyalkyl thiazoles: A novel series of potent, orally active and enantioselective inhibitors of 5-lipoxygenase

M. Edwards, R. McMillan, T. G. Bird, 1991, Agents and Actions.

Collagenase production by synovial fibroblasts treated with phorbol myristate acetate.

C. Brinckerhoff, E. D. Harris, R. McMillan, 1979, Arthritis and rheumatism.

Malonaldehyde formation in intact platelets is catalysed by thromboxane synthase.

D. Macintyre, A. Booth, R. McMillan, 1978, The Biochemical journal.

Inhibition by retinoic acid of collagenase production in rheumatoid synovial cells.

C. Brinckerhoff, J. Dayer, E. D. Harris, 1980, The New England journal of medicine.

Agonist-induced calcium flux, phosphoinositide metabolism, aggregation and enzyme secretion in human neutrophils

D. Macintyre, D. Macintyre, R. McMillan, 1988, Agents and Actions.

Pre‐clinical pharmacology of ICI D2138, a potent orally‐active non‐redox inhibitor of 5‐lipoxygenase

R. McMillan, G. C. Crawley, S. J. Foster, 1992, British journal of pharmacology.

Selective chiral inhibitors of 5‐lipoxygenase with anti‐inflammatory activity

R. McMillan, J. Girodeau, S. J. Foster, 1990, British journal of pharmacology.

2‐Substituted indazolinones: orally active and selective 5‐lipoxygenase inhibitors with anti‐inflammatory activity

R. McMillan, S. J. Foster, P. Bruneau, 1990, British journal of pharmacology.

Leukotrienes in respiratory disease.

R. McMillan, 2001, Paediatric respiratory reviews.

14 – Approaches to Novel Anti-arthritic Drugs by Modulation of the Arachidonic Acid Cascade

R. McMillan, S. J. Foster, J. Shaw, 1995 .

Discovery of ZD2138, a Potent, Selective, Well-Tolerated, Nonredox Inhibitor of the Enzyme 5-Lipoxygenase

R. McMillan, G. C. Crawley, S. J. Foster, 1995 .

Designing therapeutically effective 5-lipoxygenase inhibitors.

R. McMillan, E. Walker, 1992, Trends in pharmacological sciences.

(Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity.

M. Edwards, R. McMillan, T. G. Bird, 1991, Journal of medicinal chemistry.

Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity.

M. Edwards, R. McMillan, P. Bruneau, 1991, Journal of medicinal chemistry.

Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet‐activating factor: an ultrastructural and pharmacological study

D. Macintyre, C. Jones, R. McMillan, 1993, Journal of leukocyte biology.

Leukotriene B4 and inflammatory disease

R. McMillan, S. J. Foster, 1988, Agents and Actions.

Specificity of glucocorticoid inhibition of synovial prostaglandin synthesis

C. Brinckerhoff, E. D. Harris, R. McMillan, 1980 .

Simple, sensitive fluorimetric assay for malondialdehyde production by blood platelets.

D. Macintyre, R. McMillan, J. Gordon, 1977, Thrombosis research.

Metabolism of unsaturated fatty acids by RBL-1 5-lipoxygenase: influence of substrate solubility and product inactivation.

R. McMillan, D. Masters, V. Jacobs, 1989, Biochimica et biophysica acta.

Biosynthesis of Leukotriene B4 in Human Leukocytes

P. Bernstein, R. McMillan, D. Masters, 1985 .

Interactions of murine macrophages with monosodium urate crystals: stimulation of lysosomal enzyme release and prostaglandin synthesis.

E. D. Harris, R. McMillan, P. Hasselbacher, 1981, The Journal of rheumatology.

Are tolfenamic acid and tenidap dual inhibitors of 5-lipoxygenase and cyclo-oxygenase?

R. McMillan, K. Proudman, 1991, Agents and Actions.

Collagenase release from synovial fibroblasts: relationship to fatty acid release and prostaglandin synthesis

C. Brinckerhoff, E. D. Harris, R. McMillan, 1980 .

Induction of collagenase and prostaglandin synthesis in synovial fibroblasts treated with monosodium urate crystals

C. Vater, E. D. Harris, R. McMillan, 1981, The Journal of pharmacy and pharmacology.

Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors.

R. McMillan, T. G. Bird, G. C. Crawley, 1992, Journal of medicinal chemistry.

Monosodium urate monohydrate stimulates release of lysosomal enzymes and prostaglandins from macrophages

E. D. Harris, R. McMillan, P. Hasselbacher, 1980 .

The presence of a prostaglandin-like substance in the skin of the plaice, Pleuronectes platessa L.

R. McMillan, A. Anderson, L., 2006 .

Regulation of macrophage lysosomal enzyme secretion: role of arachidonate metabolites, divalent cations and cyclic AMP.

D. Macintyre, J. Beesley, R. McMillan, 1980, Journal of cell science.

Stimulation of human platelets by carrageenans

D. Macintyre, R. McMillan, J. L. Gordon, 1979, The Journal of pharmacy and pharmacology.

Is antiflammin p1 a phospholipase a 2 inhibitor

R. McMillan, D. Masters, A. Dutta, 1989 .

Stimulation of secretion of collagenase and prostaglandin E2 by synovial fibroblasts in response to crystals of monosodium urate monohydrate: a model for joint destruction in gout.

C. Vater, E. D. Harris, R. McMillan, 1981, Transactions of the Association of American Physicians.

Effect of divalent cations on lysosomal enzyme release from macrophages

D. Macintyre, R. McMillan, '. J.L.GORDON, 2006 .

Malondialdehyde production and the release reaction in rat blood platelets: inhibition by aspirin and indomethacin ex vivo [proceedings].

D. Macintyre, R. McMillan, J. Gordon, 1976, British Journal of Pharmacology.

Stimulation of platelets and macrophages by carrageenin [proceedings].

D. Macintyre, R. McMillan, J. Gordon, 1977, British Journal of Pharmacology.